Evidence map›Paper›PMID 32436042›Full record

ArticleMolecular biology reports2020

Evaluation of the biocompatibility of the GSH-coated Ag

Duygu Aydemir, Mahshid Hashemkhani, Havva Yagci Acar, Nuriye Nuray Ulusu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Revealing the secrets of Blue Zones.Frontiers in pharmacology · 2024
    Review
  6. Article
  7. Article
  8. Effects of theFrontiers in endocrinology · 2023
    Article
  9. Advances in optical molecular imaging for neural visualization.Frontiers in bioengineering and biotechnology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Duygu AydemirDepartment of Medical Biochemistry, School of Medicine, Koc University, Sariyer, 34450, Istanbul, Turkey.
Mahshid HashemkhaniMaterials Science and Engineering, Koc University, Sariyer, 34450, Istanbul, Turkey.
Havva Yagci AcarMaterials Science and Engineering, Koc University, Sariyer, 34450, Istanbul, Turkey. fyagci@ku.edu.tr.
Nuriye Nuray UlusuDepartment of Medical Biochemistry, School of Medicine, Koc University, Sariyer, 34450, Istanbul, Turkey. nulusu@ku.edu.tr.ORCID http://orcid.org/0000-0002-3173-1389

Funding

KUTTAM 252-172
6 · The paper itself

Abstract

Near-infrared quantum dots (NIR QDs) are promising candidate for the fluorescent probes due to their better penetration depth, long-lived luminescence with size-tunable photoluminescence wavelengths. Glutathione-coated silver sulfide quantum dots (GSH-Ag

Indexed as

Cell SurvivalCoated Materials, BiocompatibleGlutathioneGlutathione ReductaseHEK293 CellsHumansMaterials TestingOxidative StressQuantum DotsSilverSilver CompoundsCoated Materials, BiocompatibleGlutathioneGlutathione ReductaseSilverSilver Compoundssilver sulfideBiocompatibleGSHGSH-Ag2S QDICP-MSOptical probeOxidative stressQuantum dot

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.